Business / Finance

RSS

NorthStar Anesthesia announces new partnership with MetroWest Medical Center

NorthStar Anesthesia announced today a new partnership with facilities on both campuses of MetroWest Medical Center. Framingham Union Hospital in Framingham, Mass. and Leonard Morse Hospital in Natick, Mass. serve local communities west of Boston and are the newest healthcare facilities to implement the NorthStar model of anesthesia care.

20 Jul 2013

Whittier IPA signs agreement with Alere Accountable Care Solutions to build community-wide HIE

Whittier Independent Practice Association, of Newburyport, Massachusetts, announced that it has signed an agreement with Alere Accountable Care Solutions to build a community-wide health information exchange.

20 Jul 2013

HCA signs definitive agreement to acquire three Tampa Bay hospitals from IASIS

HCA and IASIS Healthcare LLC today announced the signing of a definitive agreement for the sale of three Tampa Bay hospitals—Palms of Pasadena Hospital, Memorial Hospital of Tampa and Town & Country Hospital—by IASIS to HCA West Florida.

19 Jul 2013

NGM Biopharmaceuticals announces completion of $50 million Series C financing

NGM Biopharmaceuticals, Inc. announced today the successful completion of a $50 million Series C financing to support advancing its portfolio of potential therapeutics for the treatment of diabetes, obesity and other cardio-metabolic diseases.

19 Jul 2013

Bausch + Lomb obtains option to license MIM-D3 for treatment of dry eye syndrome

Bausch + Lomb, the global eye health company, and Mimetogen Pharmaceuticals Inc. today announced that Bausch + Lomb has acquired an option to license an investigational compound currently in Phase 2 development for the treatment of dry eye syndrome, a condition that affects millions of people worldwide.

19 Jul 2013

Aquavit Pharmaceuticals signs licensing agreement with U-Bio Med for microneedle technology

Aquavit Pharmaceuticals, Inc. announces it has signed a definitive licensing agreement with U-Bio Med Inc., a medical technology device company in South Korea, for the worldwide commercialization of the company's microneedle device technology.

19 Jul 2013

Ensemble Therapeutics announces initiation of drug discovery collaboration with Alexion subsidiary

Ensemble Therapeutics, a biotechnology company developing Ensemblins, a novel class of small molecule therapeutics with the potential to modulate targets typically addressed by biologics, today announced the initiation of a drug discovery collaboration with a subsidiary of Alexion Pharmaceuticals, Inc., the global biopharmaceutical company focused on developing and commercializing life-transforming therapies for patients with life-threatening, ultra-rare disorders.

18 Jul 2013

Audentes Therapeutics closes $30 million Series A financing

Audentes Therapeutics, Inc., a recently founded biotechnology company dedicated to the development of innovative treatments for rare muscle diseases, today announced the closing of a $30 million Series A financing.

18 Jul 2013

Danaher reports 4% increase in Q2 revenues

Danaher Corporation today announced results for the second quarter of 2013. All financial metrics in this release reflect only the Company's continuing operations unless otherwise noted.

From Danaher 18 Jul 2013

Quest Diagnostics completes sale of ibrutinib commercialization rights to Royalty Pharma

Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced today that it has completed the sale of its rights to royalties from commercialization of the drug candidate ibrutinib to Royalty Pharma, the industry leader in acquiring royalty interests in marketed and late stage biopharmaceutical products, for $485 million in cash.

From Quest Diagnostics 18 Jul 2013

AbGenomics raises $9.6M for advancing therapeutic antibodies for autoimmune diseases, cancers

AbGenomics International announced today that it has raised $9.6 million in current financing round.

18 Jul 2013

Rexahn Pharmaceuticals signs license agreement with UMB for novel drug delivery platform

Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, announced today that it has signed an exclusive license agreement with the University of Maryland, Baltimore for a novel drug delivery platform, Nano-Polymer-Drug Conjugate Systems.

17 Jul 2013

ComQi, Aceso partner to serve healthcare sector with turn-key digital media solutions

ComQi, the global multi-channel message management company, and Aceso, a healthcare management and communications solutions provider, announced their partnership in serving the healthcare sector with turn-key digital media solutions.

17 Jul 2013

Mindray acquires ZONARE Medical Systems

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today that it has completed the acquisition of ZONARE Medical Systems, Inc., an ultrasound technology leader in the high-end radiology segment pursuant to the terms of the previously announced definitive agreement entered into on June 12, 2013.

From Mindray 17 Jul 2013

Spectrum Pharmaceuticals enters into agreement to acquire Talon Therapeutics

Spectrum Pharmaceuticals, Inc., a biotechnology company with fully-integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that, through a wholly-owned subsidiary, the company entered into an agreement to acquire Talon Therapeutics, Inc., a biopharmaceutical company based in South San Francisco, California, and expects to complete the acquisition within one day.

17 Jul 2013

Sequella licenses Pfizer's exclusive worldwide rights to develop, commercialize sutezolid

Sequella, a clinical-stage pharmaceutical company commercializing novel antibiotics to treat life-threatening infectious diseases, today announced that it has licensed Pfizer Inc's exclusive worldwide rights to develop and commercialize sutezolid, a Phase 2 oxazolidinone antibiotic currently in development for the treatment of tuberculosis.

17 Jul 2013

Catholic Health Initiatives creates new MSO to deliver physician-management services

Catholic Health Initiatives has formed a new management-services organization to deliver key business functions and physician-management services under a centralized, national organization across eight divisions.

17 Jul 2013

OneHealth Solutions signs strategic alliance with New Directions Behavioral Health

OneHealth Solutions, Inc., the leading behavior change platform company improving health outcomes and the cost of care for patients, providers, payers and employers, has entered into a strategic alliance with New Directions Behavioral Health, one of the fastest growing behavioral health care companies in the nation, to expand services into eHealth, mHealth and social networking for its members.

16 Jul 2013

LodgeNet Healthcare becomes SONIFI HEALTH Solutions

LodgeNet Healthcare, the leading provider of integrated patient engagement solutions, announced today that post-acquisition, it has been rebranded as SONIFI HEALTH Solutions.

16 Jul 2013

Zecotek partners with Hamamatsu to commercialize existing imaging technologies

Zecotek Photonics Inc., a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that its wholly owned subsidiary Zecotek Imaging Systems Pte. Ltd. has signed a joint collaboration partnership agreement with Hamamatsu Photonics (Tokyo: 6965) of Japan to commercialize existing imaging technologies and to collaborate on the upgrade and manufacture of photo detectors, integrated detector modules (IDM) and associated electronics and data acquisition modules for the imaging markets at large.

16 Jul 2013

Business / Finance

NorthStar Anesthesia announces new partnership with MetroWest Medical Center

Whittier IPA signs agreement with Alere Accountable Care Solutions to build community-wide HIE

HCA signs definitive agreement to acquire three Tampa Bay hospitals from IASIS

NGM Biopharmaceuticals announces completion of $50 million Series C financing

Bausch + Lomb obtains option to license MIM-D3 for treatment of dry eye syndrome

Aquavit Pharmaceuticals signs licensing agreement with U-Bio Med for microneedle technology

Ensemble Therapeutics announces initiation of drug discovery collaboration with Alexion subsidiary

Audentes Therapeutics closes $30 million Series A financing

Danaher reports 4% increase in Q2 revenues

Quest Diagnostics completes sale of ibrutinib commercialization rights to Royalty Pharma

AbGenomics raises $9.6M for advancing therapeutic antibodies for autoimmune diseases, cancers

Rexahn Pharmaceuticals signs license agreement with UMB for novel drug delivery platform

ComQi, Aceso partner to serve healthcare sector with turn-key digital media solutions

Mindray acquires ZONARE Medical Systems

Spectrum Pharmaceuticals enters into agreement to acquire Talon Therapeutics

Sequella licenses Pfizer's exclusive worldwide rights to develop, commercialize sutezolid

Catholic Health Initiatives creates new MSO to deliver physician-management services

OneHealth Solutions signs strategic alliance with New Directions Behavioral Health

LodgeNet Healthcare becomes SONIFI HEALTH Solutions

Zecotek partners with Hamamatsu to commercialize existing imaging technologies

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News